Related Experiment Videos

Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden

Stellan Mörner1, Pascale Richard, Elsadig Kazzam

  • 1Department of Medicine, University Hospital, Umeå, Sweden. stellan.morner@medicin.umu.se

Insights

This study identified 11 mutations, including six novel ones, in sarcomeric protein genes causing hypertrophic cardiomyopathy (HCM) in northern Sweden. Myosin-binding protein C gene mutations were most common, often leading to later disease onset.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac disease.
  • Mutations in sarcomeric protein genes are a common cause of HCM.
  • Understanding genotype-phenotype correlations is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate the genetic basis of HCM in northern Sweden.
  • To identify specific mutations in sarcomeric protein genes associated with HCM.
  • To correlate identified genotypes with clinical phenotypes.

Main Methods:

  • Mutation analysis of eight key sarcomeric protein genes in 46 unrelated individuals with HCM.
  • Genes analyzed include beta-myosin heavy chain, myosin-binding protein C, troponin T, alpha-tropomyosin, myosin light chains, troponin I, and alpha-actin.
  • Genotyping was performed on familial and sporadic HCM cases.

Main Results:

  • Eleven mutations were identified in 13 individuals, with six being novel.
  • Myosin-binding protein C gene mutations were the most prevalent (7 mutations).
  • Beta-myosin heavy chain gene mutations were less frequent than previously reported; troponin I and regulatory myosin light chain genes had one mutation each.

Conclusions:

  • This is the first genetic study of HCM in a Swedish population.
  • Myosin-binding protein C gene mutations are the most common cause of HCM in northern Sweden.
  • HCM associated with myosin-binding protein C mutations may present with later onset, necessitating consideration in clinical evaluations, especially in young adults with incomplete penetrance.

Related Concept Videos